ASCFX
Price
$29.35
Change
-$0.18 (-0.61%)
Updated
Jul 31 closing price
Net Assets
130.02M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

ASCFX vs NAESX

ASCFX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
ASCFX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASCFX is a Hold and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. ASCFX (130M). NAESX pays higher dividends than ASCFX: NAESX (1.10) vs ASCFX (0.24). ASCFX was incepted earlier than NAESX: ASCFX (8 years) vs NAESX (66 years). ASCFX (0.90) is less costly to investors than NAESX (0.17). ASCFX is a more actively managed with annual turnover of: 95.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than ASCFX: NAESX (0) vs ASCFX (2500000). ASCFX annual gain was more profitable for investors over the last year : 25.14 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. ASCFX (8.34).
ASCFXNAESXASCFX / NAESX
Total Expense Ratio0.770.17453%
Annual Report Gross Expense Ratio0.900.17529%
Fund Existence8 years66 years-
Gain YTD19.06714.563131%
Front LoadN/AN/A-
Min. Initial Investment25000000-
Min. Initial Investment IRAN/AN/A-
Net Assets130M189B0%
Annual Yield % from dividends0.241.1022%
Returns for 1 year25.1422.56111%
Returns for 3 years34.7343.3080%
Returns for 5 years8.3434.9524%
Returns for 10 yearsN/A155.28-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv